Brinker Capital Investments, LLC Alnylam Pharmaceuticals, Inc. Transaction History
Brinker Capital Investments, LLC
- $5.01 Billion
- Q4 2022
A detailed history of Brinker Capital Investments, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 2,512 shares of ALNY stock, worth $728,379. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,512
Previous 2,653
5.31%
Holding current value
$728,379
Previous $531,000
12.24%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding ALNY
# of Institutions
720Shares Held
111MCall Options Held
978KPut Options Held
881K-
Capital World Investors Los Angeles, CA16.7MShares$4.86 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$3.79 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.77 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$2.07 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.28 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $35.7B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...